Wright Medical Group N.V. (WMGI) [Rocket]

In millions, except per share items	Dec-29-19	Dec-30-18	Dec-31-17	Dec-25-16	Dec-27-15	Dec-31-14	Dec-31-13	Dec-30-12
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
United States	706.3	623.5	554.5	507.5	299.8	212.1	177.6	156.8
International	214.6	212.7	190.5		105.5	86.0	64.7
Total extremities				83.0	241.1	196.8	355.3	224.9
Other				99.8
Total revenues	920.9	836.2	745.0	690.4	405.3	298.0	242.3	277.5
Revenue growth [+]	10.1%	12.2%	7.9%	70.3%	36.0%	23.0%	-12.7%	6.3%
United States	13.3%	12.4%	9.3%	69.3%	41.4%	19.4%	13.3%	10.8%
International	0.9%	11.6%			22.7%	32.9%
Total extremities				-65.6%	22.5%	-44.6%	58.0%	9.8%
Sports medicine and biologics								5.1%
Cost of goods sold	188.6	180.2	160.9	192.4	113.6	73.2	59.7	81.9
Gross profit	732.3	656.0	584.0	498.0	291.7	224.8	182.6	195.6
Gross margin	79.5%	78.5%	78.4%	72.1%	72.0%	75.4%	75.4%	70.5%
Selling, general and administrative	614.7	578.0	525.2	541.6	424.4	289.6	230.8	170.4
Research and development	74.1	59.1	50.1	50.5	39.3	25.0	20.3	22.5
Other operating expenses	31.9	26.7	28.4	28.8	16.8	10.0	7.5	11.0
Adjusted EBITDA	140.2	104.6	84.9	-52.7	-130.3	-68.3	-53.1	28.7
Adjusted EBITDA margin	15.2%	12.5%	11.4%	-7.6%	-32.1%	-22.9%	-21.9%	10.3%
Stock-based compensation	32.6	26.1	19.4	14.4	25.0	11.5	15.4	6.8
EBITDA [+]	107.7	78.4	65.5	-67.2	-155.3	-79.8		21.9
EBITDA growth	37.3%	19.7%	-197.6%	-56.7%	94.7%	16.5%	-413.1%	0.1%
EBITDA margin	11.7%	9.4%	8.8%	-9.7%	-38.3%	-26.8%	-28.3%	7.9%
Depreciation and amortization	64.1	59.5	56.8	27.0	16.8	10.0		18.5
EBITA	43.5	18.9	8.7	-94.1	-172.0	-89.8	-68.5	3.4
EBITA margin	4.7%	2.3%	1.2%	-13.6%	-42.4%	-30.1%	-28.3%	1.2%
Amortization of intangibles	31.9	26.7	28.4	28.8	16.8	10.0	7.5	11.7
EBIT [+]	11.6	-7.8	-19.7	-123.0	-188.8	-99.8	-76.0	-8.4
EBIT growth	-248.6%	-60.4%	-84.0%	-34.9%	89.1%	31.4%	808.7%	33.5%
EBIT margin	1.3%	-0.9%	-2.6%	-17.8%	-46.6%	-33.5%	-31.3%	-3.0%
Non-recurring items [+]							206.2	20.0
Asset impairment							206.2
Unusual expense								19.2
Interest expense, net [+]	28.5	30.6	24.6	18.7	11.2	17.4	16.0	3.4
Interest expense	28.5	30.6	24.6	18.7	11.2	17.4	16.0	3.7
Interest income								0.3
Other income (expense), net [+]	-62.2	-131.5	-55.6	-36.7	-41.0	-129.6	67.8	-1.0
Gain (loss) on debt retirement								-0.6
Gain (loss) on foreign currency transactions								-0.5
Other	-9.9	-81.8	-5.6	3.1	-10.9	129.6	-67.8	0.1
Pre-tax income	-79.2	-169.8	-99.9	-178.3	-241.0	-246.8	-230.4	-32.7
Income taxes	13.0	-0.5	-35.0	-13.4	-3.7	-6.3	49.8	-10.9
Tax rate		0.3%	35.0%	7.5%	1.5%	2.6%		33.5%
Net income	-114.2	-169.5	-202.6	-432.4	-298.7	-259.7	-273.9	-21.7
Net margin	-12.4%	-20.3%	-27.2%	-62.6%	-73.7%	-87.1%	-113.0%	-7.8%

Basic EPS [+]	($0.73)	($1.50)	($0.62)	($1.60)	($3.66)	($4.69)	($5.82)	($0.54)
Growth	-51.6%	142.1%	-61.2%	-56.3%	-21.9%	-19.5%	973.2%	-31.9%
Diluted EPS [+]	($0.73)	($1.50)	($0.62)	($1.60)	($3.66)	($4.69)	($5.82)	($0.54)
Growth	-51.6%	142.1%	-61.2%	-56.3%	-21.9%	-19.5%	973.2%	-31.9%

Shares outstanding (basic) [+]	126.6	112.6	104.5	103.0	64.8	51.3	48.1	40.1
Growth	12.4%	7.7%	1.5%	58.9%	26.3%	6.6%	20.1%	4.8%
Shares outstanding (diluted) [+]	126.6	112.6	104.5	103.0	64.8	51.3	48.1	40.1
Growth	12.4%	7.7%	1.5%	58.9%	26.3%	6.6%	20.1%	4.8%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.